FoxFeed Blog
Latest Blog Posts Tagged "Podcast"
Podcast: Teaching Old Drugs New Tricks
July 17, 2017
Scientists are testing drugs used for high blood pressure and diabetes for their effects on Parkinson's disease. MJFF CEO Todd Sherer, PhD, discusses this tactic of drug repurposing.
Podcast: Is Parkinson's an Autoimmune Disease?
July 11, 2017
In the latest in our "Getting to a Cure: Science behind the Search" series, we cover the proposed connection between sticky protein alpha-synuclein and the immune system.
Podcast: Young-Onset Parkinson's Disease
June 14, 2017
Nancy Mulhearn, who was diagnosed with Parkinson's at age 44, shares her experiences with the disease.
Podcast: Sleep Disturbances in Parkinson's
May 15, 2017
Carlos Singer, MD, of the University of Miami discusses common sleep problems in Parkinson's and how to treat them.
Podcast: Urinary Problems in Parkinson's Disease
April 10, 2017
Urinary function is governed by the body's autonomic nervous system. In Parkinson's, urinary function can be thrown off balance, but urinary problems aren't always recognized by patients.
Podcast: Parkinson's Genetics
February 06, 2017
Barbara and Jay Robinson discuss their decision to participate in Parkinson's genetics research.
Podcast: Gut Bacteria and Parkinson's Connection
January 17, 2017
Sarkis Mazmanian, PhD, of CalTech discusses what we know about the gut bacteria and Parkinson's connection in our "Getting to a Cure: The Science behind the Search" podcast series.
Podcast: Parkinson's Common Denominator -- A Sticky Protein
November 11, 2016
Dr. Jamie Eberling, PhD, dicusses alpha-synuclein, a protein that clumps in brain cells of nearly everyone with Parkinson's disease.
Blood Pressure and Parkinson's
October 13, 2016
Dr. Anna Hohler speak to MJFF about blood pressure changes and Parkinson's disease.
Podcast: Learning the Language of LRRK2
October 11, 2016
In this podcast, MJFF staff scientist Marco Baptista, PhD, discusses the genetics and biology of LRRK2 and the role of the Foundation in advancing development of LRRK2 therapeutics.
Popular Topics
